ArticleClinical breast cancer2018

Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.

Jane Meisel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.